A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(02)85045-7 ◽

2002 ◽

Vol 24 (3) ◽

pp. 445-456 ◽

Author(s):

Mark B. Abelson ◽

Allen P. Kaplan

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Double Blind ◽

Double Blind Placebo ◽

Conjunctival Allergen Challenge

Download Full-text

Efficacy of Ketotifen Fumarate 0.025% Ophthalmic Solution Compared With Placebo in the Conjunctival Allergen Challenge Model

Archives of Ophthalmology ◽

10.1001/archopht.121.5.626 ◽

2003 ◽

Vol 121 (5) ◽

pp. 626 ◽

Author(s):

Mark B. Abelson

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model

American Journal of Ophthalmology ◽

10.1016/s0002-9394(00)00689-9 ◽

2000 ◽

Vol 130 (6) ◽

pp. 717-723 ◽

Author(s):

Peter A Netland ◽

Charles Leahy ◽

Kathleen L Krenzer

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Ophthalmic Suspension

Download Full-text

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80199-6 ◽

2003 ◽

Vol 25 (7) ◽

pp. 1975-1987 ◽

Author(s):

H.Jerome Crampton

Keyword(s):

Controlled Trial ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Signs And Symptoms ◽

Allergic Rhinoconjunctivitis ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis

Clinical Therapeutics ◽

10.1016/s0149-2918(08)80051-3 ◽

2008 ◽

Vol 30 (7) ◽

pp. 1272-1282 ◽

Author(s):

Gail L. Torkildsen ◽

Mark B. Abelson ◽

Paul J. Gomes

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Single Center ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: A randomized, double-blind, placebo-controlled clinical cross-over-trial

Pulmonary Pharmacology & Therapeutics ◽

10.1016/j.pupt.2005.07.004 ◽

2006 ◽

Vol 19 (4) ◽

pp. 233-241 ◽

Author(s):

Kai M. Beeh ◽

Jutta Beier ◽

Michael Meyer ◽

Roland Buhl ◽

Rainer Zahlten ◽

...

Keyword(s):

Small Molecule ◽

Allergen Challenge ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83044-1 ◽

2000 ◽

Vol 22 (12) ◽

pp. 1462-1472 ◽

Author(s):

Salim Butrus ◽

Jack V. Greiner ◽

Marino Discepola ◽

Ira Finegold

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Nedocromil Sodium ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies

World Allergy Organization Journal ◽

10.1097/01.wox.0000412127.79639.64 ◽

2012 ◽

Vol 5 ◽

pp. S116-S117

Author(s):

Michael S. Blaiss ◽

Maria Tort

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.04.011 ◽

2005 ◽

Vol 27 (5) ◽

pp. 568-577 ◽

Author(s):

Jack V. Greiner ◽

Ira J. Udell

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Pheniramine Maleate ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model

Current Medical Research and Opinion ◽

10.1185/030079904125004330 ◽

2004 ◽

Vol 20 (8) ◽

pp. 1227-1233 ◽

Author(s):

Bobby Q. Lanier ◽

Ira Finegold ◽

Peter D’Arienzo ◽

David Granet ◽

Arthur B. Epstein ◽

...

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge

Download Full-text

Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

Clinical Ophthalmology ◽

10.2147/opth.s185835 ◽

2018 ◽

Vol Volume 12 ◽

pp. 2617-2628 ◽

Author(s):

Edward Meier ◽

Gail Torkildsen ◽

Paul Gomes ◽

Mark C. Jasek

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Phase Iii ◽

Phase Iii Trials ◽

Conjunctival Allergen Challenge

Download Full-text